Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer
The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.
Other: blood sampels from vena rectalis superior and vena cubiti
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
- The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival. [ Time Frame: after the study is complete ] [ Designated as safety issue: No ]
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|
|Biomarkeres||Other: blood sampels from vena rectalis superior and vena cubiti|
Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected.
A total of 50 patients will be included in this study.
The study is approved by the local scientific ethical committee No. S-20100006
Please refer to this study by its ClinicalTrials.gov identifier: NCT01706809
|Vejle, Denmark, 5000|
|Contact: Hans Rahr, MD 7940 5600 ext 0045 firstname.lastname@example.org|